Pfizer

1 insight

Brewed Up Insights

Pfizer India's Q2 FY27 profit: ₹132 crore for a ₹1,250 crore brand

Much of Pfizer Ltd's 66% profit rise in Q2 FY27 is a one-time ₹132 crore for dropping Minipress XL, a brand its parent sold the same day for ₹1,250 crore.

Read more →

3 charts

A bar of Pfizer Ltd's ₹422.83 crore profit before tax split into ₹290.77 crore from the business and ₹132.06 crore from the Minipress XL payment.A third of Pfizer Ltd's Q2 FY27 pre-tax profit was 1 payment2 bars: Pfizer Inc paid Pfizer Ltd ₹131.38 crore to stop selling Minipress XL, and Novartis India paid Pfizer Inc ₹1,250 crore for the Minipress trademarks in India.Pfizer Inc got 9.5x for Minipress what it paid Pfizer LtdBars of Minipress XL's yearly sales in India: ₹179 crore to July 2022, ₹211 crore, ₹223 crore, ₹249 crore, and ₹228 crore to July 2026.Minipress XL sold ₹228 crore a year before Pfizer Ltd gave it up

Every company we have written about →

Get in touch